Literature DB >> 18191709

Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab.

David I Smith, Michael P Heffernan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191709     DOI: 10.1016/j.jaad.2006.05.035

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  Vitiligo during Treatment of Crohn's Disease with Adalimumab: Adverse Effect or Co-Occurrence?

Authors:  Celia Posada; Angeles Flórez; Ana Batalla; Juan José Alcázar; Daniel Carpio
Journal:  Case Rep Dermatol       Date:  2011-02-05

Review 2.  Advances in vitiligo: Update on therapeutic targets.

Authors:  Yifei Feng; Yan Lu
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

3.  Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.